1. Ackah J.K. [et al.]. Antimicrobial prophylaxis in adult cardiac surgery in the United Kingdom and Republic of Ireland//Journal of infection prevention. 2021. N 2 (22). Р. 83 - 90.

2. Adam E.L. [et al.]. Case series of infective endocarditis caused by Granulicatella species//International Journal of Infectious Diseases. 2015. N 31 (31). P. 56 - 58.

3. Afonso L. [et al.]. Echocardiography in Infective Endocarditis: State of the Art//Current Cardiology Reports. 2017. Vol. 19. N 12. 1 - 13 p.

4. AGGARWAL N. [et al.]. Retrospective analysis of outcome of pregnancy in women with congenital heart disease: Single - centre experience from North India//Australian and New Zealand Journal of Obstetrics and Gynaecology. 2009. N 4 (49). P. 376 - 381.

5. Ahuja T., Fong K., Louie E. Combination antifungal therapy for treatment of Candida parapsilosis prosthetic valve endocarditis and utility of T2Candida Panel(R): A case series//IDCases. 2019. (15). P. e00525.

6. Ainsworth B.E. [et al.]. 2011 Compendium of Physical Activities: a second update of codes and MET values.//undefined. 2011. N 8 (43). P. 1575 - 1581.

7. Akhyari P. [et al.]. Is simultaneous splenectomy an additive risk factor in surgical treatment for active endocarditis?//Langenbeck's Archives of Surgery. 2012. N 8 (397). C. 1261 - 1266.

8. Aksoy O. [et al.]. Early Surgery in Patients with Infective Endocarditis: A Propensity Score Analysis//Clinical Infectious Diseases. 2007. N 3 (44). P. 364 - 372.

9. Al - Omari A. [et al.]. Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review//BMC Infectious Diseases. 2014. N 1 (14). P. 140.

10. Alagna L. [et al.]. Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis - Prospective Cohort Study//Clinical Microbiology and Infection. 2014. N 6 (20). P. 566 - 575.

11. Amat - Santos I.J. [et al.]. Infective Endocarditis After Transcatheter Aortic Valve Implantation//Circulation. 2015. N 18 (131). P. 1566 - 1574.

12. Ambrosioni J. [et al.]. The Changing Epidemiology of Infective Endocarditis in the Twenty - First Century//Current Infectious Disease Reports. 2017. N 5 (19). P. 21.

13. Anavekar N.S. [et al.]. Impact of Prior Antiplatelet Therapy on Risk of Embolism in Infective Endocarditis//Clinical Infectious Diseases. 2007. N 9 (44). P. 1180 - 1186.

14. Anguera I, Miro JM, Evangelista A, Cabell CH, San Roman JA V.I. [et al.]. Periannular complications in infective endocarditis involving native aortic valves.//Am J Cardiol. 2006. N 98. P. 1254 - 1260.

15. Anguera I. [et al.]. Aorto - cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality//European Heart Journal. 2005. N 3 (26). P. 288 - 297.

16. Anguera I. [et al.]. Periannular Complications in Infective Endocarditis Involving Native Aortic Valves//The American Journal of Cardiology. 2006. N 9 (98). P. 1254 - 1260.

17. Asgeirsson H., Thalme A., Weiland O. Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs//Medicine. 2016. N 49 (95). P. e5617.

18. Baddour Correction//Circulation. 2005. N 15 (112). P. 2374 - 2374.

19. Baddour L.M. [et al.]. Nonvalvular Cardiovascular Device - Related Infections//Circulation. 2003. N 16 (108). P. 2015 - 2031.

20. Baddour L.M. [et al.]. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association//Circulation. 2015. Vol. 132. N 15. 1435 - 1486 p.

21. Bai A.D. [et al.]. Diagnostic Accuracy of Transthoracic Echocardiography for Infective Endocarditis Findings Using Transesophageal Echocardiography as the Reference Standard: A Meta - Analysis//Journal of the American Society of Echocardiography. 2017. N 7 (30). P. 639 - 646.e8.

22. Bartash R., Nori P. Beta - lactam combination therapy for the treatment of Staphylococcus aureus and Enterococcus species bacteremia: A summary and appraisal of the evidence//International Journal of Infectious Diseases. 2017. Vol. 63. 7 - 12 p.

23. Bell W.R. [et al.]. Trousseau's syndrome. Devastating coagulopathy in the absence of heparin//The American Journal of Medicine. 1985. N 4 (79). P. 423 - 430.

24. Benito N. Health Care - Associated Native Valve Endocarditis: Importance of Non - nosocomial Acquisition//Annals of Internal Medicine. 2009. N 9 (150). P. 586.

25. Bensimhon L. [et al.]. Whole body [18F] fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study//Clinical Microbiology and Infection. 2011. N 6 (17). P. 836 - 844.

26. Berdejo J. [et al.]. Evaluation of Vegetation Size and Its Relationship With Embolism in Infective Endocarditis//Circulation: Cardiovascular Imaging. 2014. N 1 (7). P. 149 - 154.

27. BERRINGTON A. Treatment of endocarditis using moxifloxacin//International Journal of Medical Microbiology. 2001. N 3 (291). P. 237 - 239.

28. Bertaglia E. [et al.]. Antibiotic prophylaxis with a single dose of cefazolin during pacemaker implantation: Incidence of long - term infective complications//PACE - Pacing and Clinical Electrophysiology. 2006. N 1 (29). P. 29 - 33.

29. Bezerra L.S. [et al.]. Antifungal Efficacy of Amphotericin B in Candida Albicans Endocarditis Therapy: Systematic Review//Brazilian Journal of Cardiovascular Surgery. 2020. N AHEAD. P. 1 - 8.

30. Bockeria L.A. [et al.]. 18F - fluorodeoxyglucose PET/CT in diagnostics of infectice endocarditis in patients with implantable cardiac devices//The Bulletin of Bakoulev Center "Cardiovascular Diseases". 2019. N 6 (20). P. 498 - 508.

31. Bongiorni M.G. [et al.]. Intracardiac Echocardiography in Patients with Pacing and Defibrillating Leads: A Feasibility Study//Echocardiography. 2008. N 6 (25). P. 632 - 638.

32. Bonzi M. [et al.]. Diagnostic accuracy of transthoracic echocardiography to identify native valve infective endocarditis: a systematic review and meta - analysis//Internal and Emergency Medicine. 2018. Т. 13. N 6. 937 - 946 p.

33. BRAUN M.U. [et al.]. Percutaneous Lead Implantation Connected to an External Device in Stimulation - Dependent Patients with Systemic Infection - A Prospective and Controlled Study//Pacing and Clinical Electrophysiology. 2006. N 8 (29). P. 875 - 879.

34. Brett M.S. Emergence of a high - level cefotaxime - resistant Streptococcus pneumoniae strain in New Zealand//Journal of Medical Microbiology. 2001. N 2 (50). P. 173 - 176.

35. Brignardello - Petersen R. Antibiotic prophylaxis probably reduces the risk of developing bacteremia in patients at risk of developing infective endocarditis who are undergoing dental extractions//Journal of the American Dental Association. 2017. Vol. 148. N 11. e169 p.

36. Brown J.P. [et al.]. Effect of patient education in the management of coronary heart disease: a systematic review and meta - analysis of randomized controlled trials//European Journal of Preventive Cardiology. 2013. N 4 (20). P. 701 - 714.

37. Bruun N.E. [et al.]. Cardiac imaging in infectious endocarditis//European Heart Journal. 2014. N 10 (35). P. 624 - 632.

38. Busca - Arenzana C. [et al.]. Non - bacterial Thrombotic Endocarditis IntechOpen, 2019. 291 - 294 p.

39. Cahill T.J. [et al.]. Antibiotic prophylaxis for infective endocarditis: A systematic review and meta - Analysis//Heart. 2017. Vol. 103. N 12. 937 - 944 p.

40. Carbone A. [et al.]. Spondylitis: A frequent and severe complication of infective endocarditis//Archives of Cardiovascular Diseases Supplements. 2020. N 1 (12). P. 82.

41. Carozza A. [et al.]. Infective endocarditis in intravenous drug abusers: patterns of presentation and long - term outcomes of surgical treatment.//The Journal of heart valve disease. 2006. N 1 (15). P. 125 - 31.

42. Casalta J. - P. [et al.]. Treatment of Staphylococcus aureus endocarditis with high doses of trimethoprim/sulfamethoxazole and clindamycin - Preliminary report//International Journal of Antimicrobial Agents. 2013. N 2 (42). P. 190 - 191.

43. Cecchi E. [et al.]. Are the Duke criteria really useful for the early bedside diagnosis of infective endocarditis? Results of a prospective multicenter trial//Italian heart journal: official journal of the Italian Federation of Cardiology. 2005. N 1 (6). P. 41 - 8.

44. Chan K. - L. [et al.]. Effect of Long - Term Aspirin Use on Embolic Events in Infective Endocarditis//Clinical Infectious Diseases. 2008. N 1 (46). P. 37 - 41.

45. Chiang K.H. [et al.]. How long should prophylactic antibiotics be prescribed for permanent pacemaker implantations? one day versus three days//Acta Cardiologica Sinica. 2013. N 4 (29). P. 341 - 346.

46. Chirouze C. [et al.]. Prognostic Factors in 61 Cases of Staphylococcus aureus Prosthetic Valve Infective Endocarditis from the International Collaboration on Endocarditis Merged Database//Clinical Infectious Diseases. 2004. N 9 (38). P. 1323 - 1327.

47. Chirouze C. [et al.]. Impact of early valve surgery on outcome of staphylococcus aureus prosthetic valve infective endocarditis: Analysis in the international collaboration of endocarditis - prospective cohort study//Clinical Infectious Diseases. 2015. N 5 (60). P. 741 - 749.

48. Choi H.N. [et al.]. Prosthetic valve endocarditis caused by HACEK organisms: A case report and systematic review of the literature//Infection and Chemotherapy. 2017. N 4 (49). P. 282 - 285.

49. Chou Y.H. [et al.]. Splenic abscess: Sonographic diagnosis and percutaneous drainage or aspiration//Gastrointestinal Radiology. 1992. N 1 (17). P. 262 - 266.

50. Chu V.H. [et al.]. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis a prospective study from the international collaboration on endocarditis//Circulation. 2015. N 2 (131). P. 131 - 140.

51. Coburn B. [et al.]. Antimicrobial susceptibilities of clinical isolates of HACEK organisms//Antimicrobial Agents and Chemotherapy. 2013. N 4 (57). P. 1989 - 1991.

52. Colen T.W. [et al.]. Radiologic manifestations of extra - cardiac complications of infective endocarditis//European Radiology. 2008. N 11 (18). P. 2433 - 2445.

53. Connolly D.L. [et al.]. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis//Journal of the American College of Cardiology. 2004. N 6 (43). P. 1134 - 1135.

54. Cornely O.A. [et al.]. Caspofungin for the treatment of less common forms of invasive candidiasis//Journal of Antimicrobial Chemotherapy. 2007. N 2 (60). P. 363 - 369.

55. Corra U. [et al.]. Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: Key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitat//European Heart Journal. 2010. N 16 (31). P. 1967 - 1974.

56. Cosgrove S.E. [et al.]. Initial Low Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic//Clinical Infectious Diseases. 2009. N 6 (48). P. 713 - 721.

57. Costa A. Da [et al.]. Antibiotic Prophylaxis for Permanent Pacemaker Implantation//Circulation. 1998. N 18 (97). P. 1796 - 1801.

58. Cremieux A. - C. [et al.]. Evaluation of Antibiotic Diffusion into Cardiac Vegetations by Quantitative Autoradiography//Journal of Infectious Diseases. 1989. N 5 (159). P. 938 - 944.

59. Cremieux A.C. [et al.]. Evaluation of Antibiotic Diffusion into Cardiac Vegetations by Quantitative Autoradiography//Journal of Infectious Diseases. 1989. N 5 (159). P. 938 - 944.

60. Dahl A. [et al.]. Enterococcus faecalis Infective Endocarditis//Circulation. 2013. N 17 (127). P. 1810 - 1817.

61. Dajani A.S. [et al.]. Prevention of bacterial endocarditis//Journal of Endodontics. 1991. N 4 (17). P. 169 - 173.

62. Dalal A. [et al.]. Intracardiac echocardiography in the detection of pacemaker lead endocarditis//Journal of the American Society of Echocardiography. 2002. N 9 (15). P. 1027 - 1028.

63. Das, MD M. [et al.]. INFECTIVE ENDOCARDITIS CAUSED BY HACEK MICROORGANISMS//Annual Review of Medicine. 1997. N 1 (48). P. 25 - 33.

64. David T.E. [et al.]. Surgical treatment of active infective endocarditis: A continued challenge//The Journal of Thoracic and Cardiovascular Surgery. 2007. N 1 (133). P. 144 - 149.

65. Davierwala P.M. [et al.]. The value of an "Endocarditis Team"//Annals of Cardiothoracic Surgery. 2019. N 6 (8). P. 621 - 629.

66. Deharo J.C. [et al.]. Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paper [Europace 2012; 14: 124 - 134. doi: 10.1093/europace/eur338]//Europace. 2012. N 4 (14). P. 460 - 460.

67. Delahaye F. [et al.]. Indications and optimal timing for surgery in infective endocarditis BMJ Publishing Group Ltd, 2004. 618 - 620 p.

68. Dellinger R.P. [et al.]. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012//Intensive Care Medicine. 2013. N 2 (39). P. 165 - 228.

69. Dhand A. [et al.]. Use of Antistaphylococcal - Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin - Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding//Clinical Infectious Diseases. 2011. N 2 (53). P. 158 - 163.

70. Dickerman S.A. [et al.]. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: An analysis from the ICE Prospective Cohort Study (ICE - PCS)//American Heart Journal. 2007. N 6 (154). P. 1086 - 1094.

71. DiNubile M.J. Short - course antibiotic therapy for right - sided endocarditis caused by Staphylococcus aureus in injection drug users//Annals of Internal Medicine. 1994. Vol. 121. N 11. 873 - 876 p.

72. Ducruet A.F. [et al.]. Intracranial infectious aneurysms: a comprehensive review//Neurosurgical Review. 2010. N 1 (33). P. 37.

73. Durack D.T. [et al.]. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings//The American Journal of Medicine. 1994. N 3 (96). P. 200 - 209.

74. Durante - Mangoni E. [et al.]. Management of Gram - negative and fungal endocarditis//International Journal of Antimicrobial Agents. 2010. N SUPPL. 2 (36).

75. Dutta T. [et al.]. Yield of Transesophageal Echocardiography for Nonbacterial Thrombotic Endocarditis and Other Cardiac Sources of Embolism in Cancer Patients With Cerebral Ischemia//The American Journal of Cardiology. 2006. N 6 (97). P. 894 - 898.

76. Duval X. [et al.]. Estimated Risk of Endocarditis in Adults with Predisposing Cardiac Conditions Undergoing Dental Procedures With or Without Antibiotic Prophylaxis//Clinical Infectious Diseases. 2006. N 12 (42). P. e102 - e107.

77. Duval X. Effect of Early Cerebral Magnetic Resonance Imaging on Clinical Decisions in Infective Endocarditis//Annals of Internal Medicine. 2010. N 8 (152). P. 497.

78. Entenza J.M. [et al.]. Efficacies of Moxifloxacin, Ciprofloxacin, and Vancomycin against Experimental Endocarditis Due to Methicillin - Resistant Staphylococcus aureus Expressing Various Degrees of Ciprofloxacin Resistance//Antimicrobial Agents and Chemotherapy. 2001. N 11 (45). P. 3076 - 3083.

79. Erba P.A. [et al.]. Added Value of 99mTc - HMPAO - Labeled Leukocyte SPECT/CT in the Characterization and Management of Patients with Infectious Endocarditis//Journal of Nuclear Medicine. 2012. N 8 (53). P. 1235 - 1243.

80. Erba P.A. [et al.]. Radiolabeled WBC Scintigraphy in the Diagnostic Workup of Patients With Suspected Device - Related Infections//JACC: Cardiovascular Imaging. 2013. N 10 (6). P. 1075 - 1086.

81. Erba P.A. [et al.]. Multimodality Imaging in Infective Endocarditis//Circulation. 2019. N 21 (140). P. 1753 - 1765.

82. Erdogan H.B. [et al.]. Endovascular treatment of intracerebral mycotic aneurysm before surgical treatment of infective endocarditis//Texas Heart Institute Journal. 2004. N 2 (31). P. 165 - 167.

83. Ertugrul Mercan M. [et al.]. Non - HACEK Gram - negative bacillus endocarditis//Medecine et Maladies Infectieuses. 2019. N 8 (49). P. 616 - 620.

84. Eudailey K. [et al.]. Aggressive infective endocarditis and the importance of early repeat echocardiographic imaging//The Journal of Thoracic and Cardiovascular Surgery. 2014. N 3 (147). P. e26 - e28.

85. Fagman E. [et al.]. ECG - gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis//European Radiology. 2012. N 11 (22). P. 2407 - 2414.

86. Falcone M., Russo A., Venditti M. Optimizing antibiotic therapy of bacteremia and endocarditis due to staphylococci and enterococci: New insights and evidence from the literature//Journal of Infection and Chemotherapy. 2015. Vol. 21. N 5. 330 - 339 p.

87. Fernandez - Hidalgo N. [et al.]. Immediate and long - term outcome of left - sided infective endocarditis. A 12 - year prospective study from a contemporary cohort in a referral hospital//Clinical Microbiology and Infection. 2012. N 12 (18). P. E522 - E530.

88. [et al.]. Contemporary Epidemiology and Prognosis of Health Care - Associated Infective Endocarditis//Clinical Infectious Diseases. 2008. N 10 (47). P. 1287 - 1297.

89. [et al.]. Infective endocarditis at autopsy: A review of pathologic manifestations and clinical correlates//Medicine. 2012. Vol. 91. N 3. 152 - 164 p.

90. Ferrari A. [et al.]. Colonoscopy is mandatory after Streptococcus bovis endocarditis: a lesson still not learned. Case report//World Journal of Surgical Oncology. 2008. N 1 (6). P. 49.

91. Ferro J.M., Fonseca A.C. Infective endocarditis 2014. 75 - 91 p.

92. Feuchtner G.M. [et al.]. Multislice Computed Tomography in Infective Endocarditis//Journal of the American College of Cardiology. 2009. N 5 (53). P. 436 - 444.

93. [et al.]. Determinants and consequences of positive valve culture when cardiac surgery is performed during the acute phase of infective endocarditis//European Journal of Clinical Microbiology and Infectious Diseases. 2020. N 4 (39). P. 629 - 635.

94. Fletcher G.F. [et al.]. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association//Circulation. 2001. N 14 (104). P. 1694 - 1740.

95. Fletcher G.F. [et al.]. Exercise Standards for Testing and Training//Circulation. 2013. N 8 (128). P. 873 - 934.

96. Foley M. Cardiac disease. In: Dildy G, Belfort M, Saade G, Phelan J H.G., Clark S E. Critical care obstetrics, 4th ed./H.G. Foley M. Cardiac disease. In: Dildy G, Belfort M, Saade G, Phelan J, E. Clark S, Oxford: Blackwell, 2004. 252 - 274 p.

97. [et al.]. Right - sided endocarditis caused by Staphylococcus aureus in drug abusers//Antimicrobial Agents and Chemotherapy. 1995. N 2 (39). P. 525 - 528.

98. Fort n J. [et al.]. Short Course Therapy for Right Side Endocarditis Due to Staphylococcus aureus in Drug Abusers: Cloxacillin versus Glycopeptides in Combination with Gentamicin//Clinical Infectious Diseases. 2001. N 1 (33). P. 120 - 125.

99. Fournier P. [et al.]. Comprehensive Diagnostic Strategy for Blood Culture - Negative Endocarditis: A Prospective Study of 819 New Cases//Clinical Infectious Diseases. 2010. N 2 (51). P. 131 - 140.

100. Fowler V.G. [et al.]. Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus//New England Journal of Medicine. 2006. N 7 (355). P. 653 - 665.

101. Francioli P. [et al.]. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility.//JAMA. 1992. N 2 (267). P. 264 - 7.

102. Francioli P. Treatment of Streptococcal Endocarditis With a Single Daily Dose of Ceftriaxone Sodium for 4 Weeks//JAMA. 1992. N 2 (267). P. 264.

103. Francioli P., Ruch W., Stamboulian D. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 Days: A prospective multicenter study//Clinical Infectious Diseases. 1995. N 6 (21). P. 1406 - 1410.

104. Gahide G. [et al.]. Preoperative Evaluation in Aortic Endocarditis: Findings on Cardiac CT//American Journal of Roentgenology. 2010. N 3 (194). P. 574 - 578.

105. [et al.]. Neurological Complications of Infective Endocarditis//Circulation. 2013. N 23 (127). P. 2272 - 2284.

106. Gardiner B.J. [et al.]. Hampered by historical paradigms - - echinocandins and the treatment of Candida endocarditis//Mycoses. 2014. N 5 (57). P. 316 - 319.

107. [et al.]. Fosfomycin - Daptomycin and Other Fosfomycin Combinations as Alternative Therapies in Experimental Foreign - Body Infection by Methicillin - Resistant Staphylococcus aureus//Antimicrobial Agents and Chemotherapy. 2013. N 1 (57). P. 606 - 610.

108. Gavalda J. [et al.]. Effect of Gentamicin Dosing Interval on Therapy of Viridans Streptococcal Experimental Endocarditis with Gentamicin plus Penicillin. 1995.

109. Geneva W.H.O. Global recommendations on physical activity for health/W.H.O. Geneva, 2010.

110. Georges H. [et al.]. Outcome and prognostic factors of patients with right - sided infective endocarditis requiring intensive care unit admission//BMC Infectious Diseases. 2018. N 1 (18). P. 85.

111. Giuliano S. [et al.]. Endocarditis caused by nutritionally variant streptococci: A case report and literature review//Infezioni in Medicina. 2012. N 2 (20). P. 67 - 74.

112. Glenny A. - M. [et al.]. Antibiotics for the prophylaxis of bacterial endocarditis in dentistry//Cochrane Database of Systematic Reviews. 2013. N 10 (2013). P. CD003813.

113. Goddard A.J.P., Tan G., Becker J. Computed tomography angiography for the detection and characterization of intra - cranial aneurysms: Current status//Clinical Radiology. 2005. N 12 (60). P. 1221 - 1236.

114. Gomes Neto M. [et al.]. Pre - and postoperative inspiratory muscle training in patients undergoing cardiac surgery: systematic review and meta - analysis//Clinical Rehabilitation. 2017. N 4 (31). P. 454 - 464.

115. [et al.]. Symptomatic Peripheral Mycotic Aneurysms Due to Infective Endocarditis//Medicine. 2014. N 1 (93). P. 42 - 52.

116. [et al.]. Non - bacterial thrombotic endocarditis in cancer patients.//Acta cardiologica. 1991. N 1 (46). P. 1 - 9.

117. Gould F.K. [et al.]. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: A report of the working party of the british society for antimicrobial chemotherapy//Journal of Antimicrobial Chemotherapy. 2012. Vol. 67. N 2. 269 - 289 p.

118. Goulenok T. [et al.]. Infective Endocarditis with Symptomatic Cerebral Complications: Contribution of Cerebral Magnetic Resonance Imaging//Cerebrovascular Diseases. 2013. N 4 (35). P. 327 - 336.

119. Grammes J.A. [et al.]. Percutaneous Pacemaker and Implantable Cardioverter - Defibrillator Lead Extraction in 100 Patients With Intracardiac Vegetations Defined by Transesophageal Echocardiogram//Journal of the American College of Cardiology. 2010. N 9 (55). P. 886 - 894.

120. Grillo S. [et al.]. Impact of - Lactam and Daptomycin Combination Therapy on Clinical Outcomes in Methicillin - susceptible Staphylococcus aureus Bacteremia: A Propensity Score - matched Analysis//Clinical Infectious Diseases. 2019. N 9 (69). P. 1480 - 1488.

121. Grob A. [et al.]. Cardiac multidetector computed tomography in infective endocarditis: a pictorial essay//Insights into Imaging. 2014. Vol. 5. N 5. 559 - 570 с.

122. Guleri A. [et al.]. Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(R) Outcomes Registry and Experience (EU - CORE)//Infectious Diseases and Therapy. 2015. N 3 (4). P. 283 - 296.

123. Habib A. [et al.]. Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections//Europace. 2013. N 2 (15). P. 227 - 235.

124. Habib G. [et al.]. Value and limitations of the duke criteria for the diagnosis of infective endocarditis//Journal of the American College of Cardiology. 1999. N 7 (33). P. 2023 - 2029.

125. Habib G. [et al.]. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)//European Heart Journal. 2009. N 19 (30). P. 2369 - 2413.

126. Habib G. [et al.]. Recommendations for the practice of echocardiography in infective endocarditis//European Journal of Echocardiography. 2010. N 2 (11). P. 202 - 219.

127. Habib G. [et al.]. 2015 ESC Guidelines for the management of infective endocarditis//European Heart Journal. 2015. N 44 (36). P. 3075 - 3128.

128. Habib G. [et al.]. The ESC - EORP EURO - ENDO (European Infective Endocarditis) registry//European Heart Journal - Quality of Care and Clinical Outcomes. 2019. N 3 (5). P. 202 - 207.

129. Habib G. [et al.]. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC - EORP EURO - ENDO (European infective endocarditis) registry: a prospective cohort study//European Heart Journal. 2019. N 39 (40). P. 3222 - 3232.

130. Hagl C. [et al.]. Replacing the ascending aorta and aortic valve for acute prosthetic valve endocarditis: is using prosthetic material contraindicated?//The Annals of Thoracic Surgery. 2002. N 5 (74). P. S1781 - S1785.

131. Hansen D. [et al.]. The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: A digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology//European journal of preventive cardiology. 2017. N 10 (24). P. 1017 - 1031.

132. Hecht S.R., Berger M. Right - sided endocarditis in intravenous drug users. Prognostic features in 102 episodes//Annals of Internal Medicine. 1992. N 7 (117). P. 560 - 566.

133. Hess A. [et al.]. Brain MRI Findings in Neurologically Asymptomatic Patients with Infective Endocarditis//American Journal of Neuroradiology. 2013. N 8 (34). P. 1579 - 1584.

134. Hill E.E. [et al.]. Abscess in infective endocarditis: The value of transesophageal echocardiography and outcome//American Heart Journal. 2007. N 5 (154). P. 923 - 928.

135. Hill E.E. [et al.]. Management of Prosthetic Valve Infective Endocarditis//The American Journal of Cardiology. 2008. N 8 (101). P. 1174 - 1178.

136. Horstkotte D. Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary The Task Force on Infective Endocarditis of the European Society of Cardiology//European Heart Journal. 2004. N 3 (25). P. 267 - 276.

137. Hosono M. [et al.]. Considerations in timing of surgical intervention for infective endocarditis with cerebrovascular complications//Journal of Heart Valve Disease. 2010. N 3 (19). P. 321 - 325.

138. Houard V. [et al.]. Prognostic value of residual vegetation after antibiotic treatment for infective endocarditis: A retrospective cohort study//International Journal of Infectious Diseases. 2020. (94). P. 34 - 40.

139. Hubert S. [et al.]. Prediction of Symptomatic Embolism in Infective Endocarditis//Journal of the American College of Cardiology. 2013. N 15 (62). P. 1384 - 1392.

140. Hui F.K. [et al.]. Mycotic aneurysm detection rates with cerebral angiography in patients with infective endocarditis//Journal of NeuroInterventional Surgery. 2015. N 6 (7). P. 449 - 452.

141. Hussain S.T. [et al.]. Tricuspid valve endocarditis//Annals of Cardiothoracic Surgery. 2017. N 3 (6). P. 255 - 261.

142. Hussein A.A. [et al.]. Microbiology of Cardiac Implantable Electronic Device Infections//JACC: Clinical Electrophysiology. 2016. N 4 (2). P. 498 - 505.

143. Incani A. [et al.]. Staphylococcus aureus bacteraemia: evaluation of the role of transoesophageal echocardiography in identifying clinically unsuspected endocarditis//European Journal of Clinical Microbiology & Infectious Diseases. 2013. N 8 (32). P. 1003 - 1008.

144. Irtyuga O.B. [et al.]. Detection rate and clinical significance of latent infective endocarditis in patients with aortic stenosis//Russian Journal of Cardiology. 2019. N 11. P. 10 - 15.

145. Isaacs D. Antibiotic prophylaxis for infective endocarditis: A systematic review and meta - analysis//Journal of Paediatrics and Child Health. 2017. Vol. 53. N 9. 921 - 922 p.

146. Iung B. [et al.]. Determinants of Cerebral Lesions in Endocarditis on Systematic Cerebral Magnetic Resonance Imaging//Stroke. 2013. N 11 (44). P. 3056 - 3062.

147. Iversen K. [et al.]. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis//New England Journal of Medicine. 2019. N 5 (380). P. 415 - 424.

148. Jang H. [et al.]. Salvage Treatment for Persistent Methicillin Resistant Staphylococcus aureus Bacteremia: Efficacy of Linezolid With or Without Carbapenem//Clinical Infectious Diseases. 2009. N 3 (49). P. 395 - 401.

149. Kahveci G. [et al.]. Prognostic Value of N - Terminal Pro - B - Type Natriuretic Peptide in Patients With Active Infective Endocarditis//American Journal of Cardiology. 2007. N 10 (99). P. 1429 - 1433.

150. Kaminsky L.A. [et al.]. Assessing Physical Activity as a Core Component in Cardiac Rehabilitation: A POSITION STATEMENT OF THE AMERICAN ASSOCIATION OF CARDIOVASCULAR AND PULMONARY REHABILITATION//Journal of cardiopulmonary rehabilitation and prevention. 2016. N 4 (36). P. 217 - 226.

151. Kang D. - H. [et al.]. Early Surgery versus Conventional Treatment for Infective Endocarditis//New England Journal of Medicine. 2012. N 26 (366). P. 2466 - 2473.

152. KARVONEN M.J., KENTALA E., MUSTALA O. The effects of training on heart rate; a longitudinal study//Annales medicinae experimentalis et biologiae Fenniae. 1957. N 3 (35). P. 307 - 315.

153. Kawata H. [et al.]. Utility and safety of temporary pacing using active fixation leads and externalized re - usable permanent pacemakers after lead extraction//Europace. 2013. N 9 (15). P. 1287 - 1291.

154. Kebar Y.M. [et al.]. Libman - Sacks endocarditis in patients with systemic lupus erythematosus with secondary antiphospholipid syndrome//Caspian Journal of Internal Medicine. 2019. N 3 (10). P. 339 - 342.

155. Kerchove L. de [et al.]. Reconstructive surgery in active mitral valve endocarditis: feasibility, safety and durability//European Journal of Cardio - Thoracic Surgery. 2007. N 4 (31). P. 592 - 599.

156. Kiefer T. [et al.]. Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure//JAMA. 2011. N 20 (306).

157. Kircher M., Lapa C. Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation//Current Cardiovascular Imaging Reports. 2017. Vol. 10. N 2.

158. Klug D. [et al.]. Systemic Infection Related to Endocarditis on Pacemaker Leads//Circulation. 1997. N 8 (95). P. 2098 - 2107.

159. Klug D. [et al.]. Risk Factors Related to Infections of Implanted Pacemakers and Cardioverter - Defibrillators//Circulation. 2007. N 12 (116). P. 1349 - 1355.

160. Knoll B. [et al.]. Infective Endocarditis Due to Penicillin - Resistant Viridans Group Streptococci//Clinical Infectious Diseases. 2007. N 12 (44). P. 1585 - 1592.

161. KORNBERGER A. [et al.]. Bridge to Recovery or Permanent System Implantation: An Eight - Year Single - Center Experience in Transvenous Semipermanent Pacing//Pacing and Clinical Electrophysiology. 2013. N 9 (36). P. 1096 - 1103.

162. Koslow M. [et al.]. The Unique Clinical Features and Outcome of Infectious Endocarditis and Vertebral Osteomyelitis Co - infection//The American Journal of Medicine. 2014. N 7 (127). P. 669.e9 - 669.e15.

163. Kotova E.O. [et al.]. Infective endocarditis: Importance of molecular biological techniques in etiological diagnosis//Terapevticheskii arkhiv. 2016. N 11 (88). P. 62 - 67.

164. Kotova E.O. [et al.]. Infective Endocarditis with Unknown Etiology: Possibilities of Conquering and Role of Microbiologistics//Kardiologiia. 2021. N 1 (61). P. 87 - 97.

165. Kuijpers J.M. [et al.]. Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: Focus on the use of prosthetic material//European Heart Journal. 2017. N 26 (38). P. 2048 - 2056.

166. Kupferwasser L.I. [et al.]. Acetylsalicylic Acid Reduces Vegetation Bacterial Density, Hematogenous Bacterial Dissemination, and Frequency of Embolic Events in Experimental Staphylococcus aureus Endocarditis Through Antiplatelet and Antibacterial Effects//Circulation. 1999. N 21 (99). P. 2791 - 2797.

167. Kusumoto F.M. [et al.]. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction//Heart Rhythm. 2017. N 12 (14). P. e503 - e551.

168. LACASSIN F. [et al.]. Procedures associated with infective endocarditis in adults//European Heart Journal. 1995. N 12 (16). P. 1968 - 1974.

169. Lamas C.C. [et al.]. Diagnosis of blood culture - negative endocarditis and clinical comparison between blood culture - negative and blood culture - positive cases//Infection. 2016. N 4 (44). P. 459 - 466.

170. Lamy B. [et al.]. How to Optimize the Use of Blood Cultures for the Diagnosis of Bloodstream Infections? A State - of - the Art//Frontiers in Microbiology. 2016. N MAY (7). P. 697.

171. Landoni G. [et al.]. Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery//New England Journal of Medicine. 2019. N 13 (380).

172. Lebeaux D. [et al.]. Aminoglycosides for infective endocarditis: time to say goodbye?//Clinical Microbiology and Infection. 2020. Vol. 26. N 6. 723 - 728 p.

173. Lee M. - R. [et al.]. Clinical Features of Right - Sided Infective Endocarditis Occurring in Non - Drug Users//Journal of Korean Medical Science. 2014. N 6 (29). P. 776.

174. Lee S.J. [et al.]. The Clinical Impacts of Apparent Embolic Event and the Predictors of In - Hospital Mortality in Patients with Infective Endocarditis//Journal of Korean Medical Science. 2014. N 12 (29). P. 1646.

175. Lennard K. [et al.]. Potential benefit of combination antifungal therapy in Aspergillus endocarditis//BMJ Case Reports. 2020. N 6 (13). P. e234008.

176. Lewis P.J. [et al.]. Teicoplanin in endocarditis: A multicentre, open european study//Chemotherapy. 1995. N 5 (41). P. 399 - 411.

177. Li J.S. [et al.]. Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis//Clinical Infectious Diseases. 2000. N 4 (30). P. 633 - 638.

178. Liesenborghs L. [et al.]. Coagulation: At the heart of infective endocarditis//Journal of Thrombosis and Haemostasis. 2020. N 5 (18). P. 995 - 1008.

179. Liesman R.M. [et al.]. Laboratory Diagnosis of Infective Endocarditis//Journal of Clinical Microbiology. 2017. N 9 (55). P. 2599 - 2608.

180. Lisnevskaia L., Murphy G., Isenberg D. Systemic lupus erythematosus Lancet Publishing Group, 2014. 1878 - 1888 p.

181. Lockhart P.B. [et al.]. Bacteremia Associated With Toothbrushing and Dental Extraction//Circulation. 2008. N 24 (117). P. 3118 - 3125.

182. Lodise T.P. [et al.]. Impact of empirical - therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin - susceptible Staphylococcus aureus//Antimicrobial Agents and Chemotherapy. 2007. N 10 (51). P. 3731 - 3733.

183. Lopes S. [et al.]. Allograft aortic root replacement in complex prosthetic endocarditis//European Journal of Cardio - Thoracic Surgery. 2007. N 1 (32). P. 126 - 130.

184. Lopez J. [et al.]. Definition, clinical profile, microbiological spectrum, and prognostic factors of early - onset prosthetic valve endocarditis//European Heart Journal. 2007. N 6 (28). P. 760 - 765.

185. L pez J. [et al.]. Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left - sided infective endocarditis//European Heart Journal. 2013. N 23 (34). P. 1749 - 1754.

186. Loyens M. [et al.]. Link between endocarditis on porcine bioprosthetic valves and allergy to pork//International Journal of Cardiology. 2013. N 2 (167). P. 600 - 602.

187. Lye D.C.B. [et al.]. Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review//European Journal of Clinical Microbiology & Infectious Diseases. 2005. N 11 (24). P. 753 - 755.

188. M. B. [et al.]. A review of combination antimicrobial therapy for enterococcus faecalis bloodstream infections and infective endocarditis//Clinical Infectious Diseases. 2018. Т. 67. N 2. 303 - 309 с.

189. Mahmood M. [et al.]. Meta - analysis of 18F - FDG PET/CT in the diagnosis of infective endocarditis//Journal of Nuclear Cardiology. 2019. N 3 (26). P. 922 - 935.

190. Majumdar A. [et al.]. Renal pathological findings in infective endocarditis.//Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. 2000. N 11 (15). P. 1782 - 7.

191. Mantovani F. [et al.]. A first described case of cancer - associated non - bacterial thrombotic endocarditis in the era of direct oral anticoagulants//Thrombosis Research. 2017. Vol. 149. 45 - 47 p.

192. Marmelo F., Rocha V., Moreira - Gon alves D. The impact of prehabilitation on post - surgical complications in patients undergoing non - urgent cardiovascular surgical intervention: Systematic review and meta - analysis//European Journal of Preventive Cardiology. 2018. N 4 (25). P. 404 - 417.

193. [et al.]. A comparison of different antibiotic regimens for the treatment of infective endocarditis//Cochrane Database of Systematic Reviews. 2020. Vol. 2020. N 5.

194. [et al.]. Analysis of mortality and risk factors associated with native valve endocarditis in drug users: The importance of vegetation size//American Heart Journal. 2005. N 5 (150). P. 1099 - 1106.

195. [et al.]. Effect of Penicillin Resistance of Streptococcus pneumoniae on the Presentation, Prognosis, and Treatment of Pneumococcal Endocarditis in Adults//Clinical Infectious Diseases. 2002. N 2 (35). P. 130 - 139.

196. Martino P. [et al.]. Teicoplanin in the treatment of gram - positive - bacterial endocarditis//Antimicrobial Agents and Chemotherapy. 1989. N 8 (33). P. 1329 - 1334.

197. Mazibuko B., Ramnarain H., Moodley J. An audit of pregnant women with prosthetic heart valves at a tertiary hospital in South Africa//Cardiovascular Journal of Africa. 2012. N 4 (23). P. 216 - 221.

198. McDonald J.R. Acute Infective Endocarditis//Infectious Disease Clinics of North America. 2009. Vol. 23. N 3. 643 - 664 p.

199. Meer J.T.M. van der [et al.]. Efficacy of antibiotic prophylaxis for prevention of native - valve endocarditis//The Lancet. 1992. N 8786 (339). P. 135 - 139.

200. Meier - Ewert H.K., Gray M. - E., John R.M. Endocardial pacemaker or defibrillator leads with infected vegetations: a single - center experience and consequences of transvenous extraction//American Heart Journal. 2003. N 2 (146). P. 339 - 344.

201. Mezzani A. [et al.]. Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac Rehabilitation//European journal of preventive cardiology. 2013. N 3 (20). P. 442 - 467.

202. Mirabel M. [et al.]. Long - term outcomes and cardiac surgery in critically ill patients with infective endocarditis//European Heart Journal. 2014. N 18 (35). P. 1195 - 1204.

203. [et al.]. Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin - Resistant Staphylococcus aureus//Antimicrobial Agents and Chemotherapy. 2009. N 10 (53). P. 4172 - 4177.

204. [et al.]. High - Dose Daptomycin plus Fosfomycin Is Safe and Effective in Treating Methicillin - Susceptible and Methicillin - Resistant Staphylococcus aureus Endocarditis//Antimicrobial Agents and Chemotherapy. 2012. N 8 (56). P. 4511 - 4515.

205. Miro J.M., Pericas J.M., Rio A. Del A new era for treating enterococcus faecalis endocarditis ampicillin plus short - course gentamicin or ampicillin plus ceftriaxone: That is the question!//Circulation. 2013. Vol. 127. N 17. 1763 - 1766 p.

206. Mohananey D. [et al.]. Association of vegetation size with embolic risk in patients with infective endocarditis a systematic review and meta - analysis//JAMA Internal Medicine. 2018. Vol. 178. N 4. 502 - 510 p.

207. Moiseev V.S. [et al.]. Infective Endocarditis in Moscow General Hospital: Clinical Characteristics and Outcomes (Single - Center 7 Years' Experience)//Kardiologiia. 2018. N 12 (58). P. 66 - 75.

208. Montoya M.E., Karnath B.M., Ahmad M. Endocarditis during Pregnancy//Southern Medical Journal. 2003. N 11 (96). P. 1156 - 1157.

209. Moons P. What do adult patients with congenital heart disease know about their disease, treatment, and prevention of complications? A call for structured patient education//Heart. 2001. N 1 (86). P. 74 - 80.

210. Moore B. [et al.]. Incidence, predictors and outcomes of infective endocarditis in a contemporary adult congenital heart disease population//International Journal of Cardiology. 2017. (249). P. 161 - 165.

211. Mora S. [et al.]. Physical Activity and Reduced Risk of Cardiovascular Events//Circulation. 2007. N 19 (116). P. 2110 - 2118.

212. Morissens M, Viart P, Tecco L, Wauthy P, Michiels S, Dessy H, Malekzadeh MS, Verbeet T C.R. Does congenital heart disease severely jeopardise family life and pregnancies? Obstetrical history of women with congenital heart disease in a single tertiary centre.//Cardiol Young. 2013. N 23. P. 41 - 46.

213. Morris N.A. [et al.]. Neurologic Complications in Infective Endocarditis: Identification, Management, and Impact on Cardiac Surgery//The Neurohospitalist. 2014. N 4 (4). P. 213 - 222.

214. [et al.]. Echocardiography in infective endocarditis: Reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach//Journal of the American College of Cardiology. 1989. N 3 (14). P. 631 - 638.

215. Murakami T. [et al.]. Factors associated with surgery for active endocarditis in congenital heart disease//International Journal of Cardiology. 2012. N 1 (157). P. 59 - 62.

216. Murashita T. Surgical Treatment for Tricuspid Valve Infective Endocarditis InTech, 2018.

217. Musci M. [et al.]. Homograft aortic root replacement in native or prosthetic active infective endocarditis: Twenty - year single - center experience//The Journal of Thoracic and Cardiovascular Surgery. 2010. N 3 (139). P. 665 - 673.

218. Nadji G. [et al.]. Heart failure in left - sided native valve infective endocarditis: characteristics, prognosis, and results of surgical treatment//European Journal of Heart Failure. 2009. N 7 (11). P. 668 - 675.

219. Najmeddin F., Khalili H. Comment on: Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy//Journal of Antimicrobial Chemotherapy. 2012. N 12 (67). P. 3016 - 3017.

220. Narducci M.L. [et al.]. Usefulness of Intracardiac Echocardiography for the Diagnosis of Cardiovascular Implantable Electronic Device - Related Endocarditis//Journal of the American College of Cardiology. 2013. N 13 (61). P. 1398 - 1405.

221. Nashef S.A.M. [et al.]. EuroSCORE II//European Journal of Cardio - Thoracic Surgery. 2012. N 4 (41). P. 734 - 745.

222. Nicolau D.P. [et al.]. Experience with a once - daily aminoglycoside program administered to 2,184 adult patients//Antimicrobial Agents and Chemotherapy. 1995. N 3 (39). P. 650 - 655.

223. Nigo M. [et al.]. What's New in the Treatment of Enterococcal Endocarditis?//Current Infectious Disease Reports. 2014. N 10 (16). P. 431.

224. Nishimura R.A. [et al.]. 2014 AHA/ACC guideline for the management of patients with valvular heart disease//The Journal of Thoracic and Cardiovascular Surgery. 2014. N 1 (148). P. e1 - e132.

225. Niwa K. Infective endocarditis in congenital heart disease: Japanese national collaboration study//Heart. 2005. N 6 (91). P. 795 - 800.

226. [et al.]. Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?//Journal of Antimicrobial Chemotherapy. 1990. N 1 (25). P. 159 - 173.

227. Nunes M.C.P. [et al.]. Outcomes of infective endocarditis in the current era: Early predictors of a poor prognosis//International Journal of Infectious Diseases. 2018. (68). P. 102 - 107.

228. Olaison L., Schadewitz K. Enterococcal Endocarditis in Sweden, 1995 - 1999: Can Shorter Therapy with Aminoglycosides Be Used?//Clinical Infectious Diseases. 2002. N 2 (34). P. 159 - 166.

229. Ong E. [et al.]. Thrombolysis for stroke caused by infective endocarditis: an illustrative case and review of the literature//Journal of Neurology. 2013. N 5 (260). P. 1339 - 1342.

230. Palestro C.J. [et al.]. Society of Nuclear Medicine Procedure Guideline for 99mTc - Exametazime (HMPAO) - Labeled Leukocyte Scintigraphy for Suspected Infection/Inflammation//Society of Nuclear Medicine Procedure Guidelines. 2004. P. 1 - 6.

231. Parra J.A. [et al.]. Detection of spleen, kidney and liver infarcts by abdominal computed tomography does not affect the outcome in patients with left - side infective endocarditis//Medicine (United States). 2018. N 33 (97). P. e11952.

232. Paturel L, Casalta JP, Habib G, Nezri M R.D. Actinobacillus actinomycetemcomitans Qeios, 2020. 98 - 118 p.

233. Pecha S. [et al.]. Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency//Europace. 2013. N 8 (15). P. 1205 - 1209.

234. [et al.]. Outpatient Parenteral Antibiotic Treatment for Infective Endocarditis: A Prospective Cohort Study From the GAMES Cohort//Clinical Infectious Diseases. 2019. N 10 (69). P. 1690 - 1700.

235. [et al.]. Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin - resistant Staphylococcus aureus: a randomized clinical trial//Clinical Microbiology and Infection. 2018. Vol. 24. N 6. 673 - 676 p.

236. Courvalin P. Synergism between and Glycopeptides against VanA - Type Methicillin - Resistant Staphylococcus aureus and Heterologous Expression of the vanA Operon//Antimicrobial Agents and Chemotherapy. 2006. N 11 (50). P. 3622 - 3630.

237. Pettersson G.B. [et al.]. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary//Journal of Thoracic and Cardiovascular Surgery. 2017. N 6 (153). P. 1241 - 1258.e29.

238. Pfister R. [et al.]. Three - dimensional compared to two - dimensional transesophageal echocardiography for diagnosis of infective endocarditis//Infection. 2016. N 6 (44). P. 725 - 731.

239. Pichlmaier M. [et al.]. Complete removal as a routine treatment for any cardiovascular implantable electronic device - associated infection//The Journal of Thoracic and Cardiovascular Surgery. 2011. N 6 (142). P. 1482 - 1490.

240. Pigrau C. [et al.]. Spontaneous pyogenic vertebral osteomyelitis and endocarditis: Incidence, risk factors, and outcome//The American Journal of Medicine. 2005. N 11 (118). P. 1287.e17 - 1287.e24.

241. Piper C. The importance of secondary mitral valve involvement in primary aortic valve endocarditis. The mitral kissing vegetation//European Heart Journal. 2002. N 1 (23). P. 79 - 86.

242. Pontikis K. [et al.]. Efficacy of tigecycline alone and in combination with gentamicin in the treatment of experimental endocarditis due to linezolid - resistant Enterococcus faecium//Antimicrobial Agents and Chemotherapy. 2013. N 7 (57). P. 3392 - 3394.

243. Pulvirenti J.J. [et al.]. Infective endocarditis in injection drug users: Importance of human immunodeficiency virus serostatus and degree of immunosuppression//Clinical Infectious Diseases. 1996. N 1 (22). P. 40 - 45.

244. Purcell J.B. [et al.]. Relation of Troponin Elevation to Outcome in Patients With Infective Endocarditis//The American Journal of Cardiology. 2008. N 10 (101). P. 1479 - 1481.

245. Rajani R., Klein J.L. Infective endocarditis: A contemporary update//Clinical Medicine, Journal of the Royal College of Physicians of London. 2020. N 1 (20). P. 31 - 35.

246. Rasmussen R. V. [et al.]. Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography//European Journal of Echocardiography. 2011. N 6 (12). P. 414 - 420.

247. Rasmussen T. Health, recovery and rehabilitation after infective endocarditis 2015.

248. Rasmussen T.B. [et al.]. A randomised clinical trial of comprehensive cardiac rehabilitation versus usual care for patients treated for infective endocarditis - the CopenHeart IE trial protocol//BMJ Open. 2012. N 6 (2). P. 1929.

249. Raymond M. [et al.]. INFECTIVE ENDOCARDITIS IN PREGNANCY: A CONTEMPORARY COHORT//Journal of the American College of Cardiology. 2020. N 11 (75). P. 2145.

250. Regitz - Zagrosek V. [et al.]. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy//Kardiologia polska. 2019. N 3 (77). P. 245 - 326.

251. Reis L.J. [et al.]. Successful Treatment of Aspergillus Prosthetic Valve Endocarditis with Oral Voriconazole//Clinical Infectious Diseases. 2005. N 5 (41). P. 752 - 753.

252. Reyes H.A. [et al.]. Successful medical treatment of infective endocarditis caused by Candida parapsilosis in an immunocompromised patient//BMJ Case Reports. 2015. (2015).

253. [et al.]. Surgical Treatment of Pacemaker and Defibrillator Lead Endocarditis//Chest. 2003. N 4 (124). P. 1451 - 1459.

254. Ritchie B.M. [et al.]. Risk factors for acute kidney injury associated with the treatment of bacterial endocarditis at a tertiary academic medical center//Journal of Chemotherapy. 2017. N 5 (29). P. 292 - 298.

255. [et al.]. Direct identification of pathogens from positive blood cultures using matrix - assisted laser desorption - ionization time - of - flight mass spectrometry//Clinical Microbiology and Infection. 2014. N 7 (20). P. O421 - O427.

256. Roos - Hesselink J.W. [et al.]. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology//European Heart Journal. 2013. N 9 (34). P. 657 - 665.

257. Rouzet F. [et al.]. Respective Performance of 18F - FDG PET and Radiolabeled Leukocyte Scintigraphy for the Diagnosis of Prosthetic Valve Endocarditis//Journal of Nuclear Medicine. 2014. N 12 (55). P. 1980 - 1985.

258. [et al.]. Pacemaker Endocarditis During 18 Years in //Scandinavian Journal of Infectious Diseases. 2004. N 9 (36). P. 674 - 679.

259. Ruttmann E. [et al.]. Neurological Outcome of Septic Cardioembolic Stroke After Infective Endocarditis//Stroke. 2006. N 8 (37). P. 2094 - 2099.

260. Salvo G. Di Endocarditis in the elderly: clinical, echocardiographic, and prognostic features//European Heart Journal. 2003. N 17 (24). P. 1576 - 1583.

261. Sambola A. [et al.]. Streptococcus agalactiae Infective Endocarditis: Analysis of 30 Cases and Review of the Literature, 1962 - 1998//Clinical Infectious Diseases. 2002. N 12 (34). P. 1576 - 1584.

262. Samuelson G. Global strategy on diet, physical activity and health//Scandinavian Journal of Nutrition. 2004. N 2 (48). P. 57 - 57.

263. [et al.]. Prognostic Stratification of Patients with Left - Sided Endocarditis Determined at Admission//The American Journal of Medicine. 2007. N 4 (120). P. 369.e1 - 369.e7.

264. Vilacosta I., Comments on: 'The infective endocarditis team: recommendations from an international working group'//Heart. 2014. N 16 (100). P. 1301.2 - 1302.

265. Sanz M. [et al.]. Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International diabetes Federation and the European Federation of Periodontology//Diabetes Research and Clinical Practice. 2018. N 2 (137). P. 231 - 241.

266. Sarrazin J. - F. [et al.]. Usefulness of Fluorine - 18 Positron Emission Tomography/Computed Tomography for Identification of Cardiovascular Implantable Electronic Device Infections//Journal of the American College of Cardiology. 2012. N 18 (59). P. 1616 - 1625.

267. Scola B. La, Raoult D. Direct Identification of Bacteria in Positive Blood Culture Bottles by Matrix - Assisted Laser Desorption Ionisation Time - of - Flight Mass Spectrometry//PLoS ONE. 2009. N 11 (4). P. e8041.

268. Selton - Suty C. [et al.]. Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1 - Year Population - Based Survey//Clinical Infectious Diseases. 2012. N 9 (54). P. 1230 - 1239.

269. Sexton D.J. [et al.]. Ceftriaxone Once Daily for Four Weeks Compared with Ceftriaxone Plus Gentamicin Once Daily for Two Weeks for Treatment of Endocarditis Due to Penicillin Susceptible Streptococci//Clinical Infectious Diseases. 1998. N 6 (27). P. 1470 - 1474.

270. Shakya S. [et al.]. Clinical Presentation of Infective Endocarditis in the Early 21st Century: A Descriptive Study//Open Forum Infectious Diseases. 2017. N suppl_1 (4). P. S559 - S559.

271. Shapira Y. [et al.]. The impact of intraoperative transesophageal echocardiography in infective endocarditis//Israel Medical Association Journal. 2007. N 4 (9). P. 299 - 302.

272. Shapiro S., Kupferwasser L.I. Echocardiography predicts embolic events in infective endocarditis: Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Card//Journal of the American College of Cardiology. 2001. N 4 (37). P. 1077 - 1079.

273. Shaw E. [et al.]. Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: Protocol of a multicentre, randomised, phase III trial//BMJ Open. 2015. N 3 (5).

274. Siciliano R.F. [et al.]. Early - onset prosthetic valve endocarditis definition revisited: Prospective study and literature review//International Journal of Infectious Diseases. 2018. (67). P. 3 - 6.

275. Smith J.R. [et al.]. High - Dose Daptomycin Therapy for Staphylococcal Endocarditis and When to Apply It//Current Infectious Disease Reports. 2014. Vol. 16. N 10.

276. Snygg - Martin U, Rasmussen RV, Hassager C, Bruun NE, Andersson R O.L. The relationship between cerebrovascular complications and previously established use of antiplatelet therapy in left - sided infective endocarditis//Scand J Infect Dis. 2011. N 43. P. 899 - 904.

277. Sohail M.R. [et al.]. Management and Outcome of Permanent Pacemaker and Implantable Cardioverter - Defibrillator Infections//Journal of the American College of Cardiology. 2007. N 18 (49). P. 1851 - 1859.

278. Sohail M.R. [et al.]. Risk Factor Analysis of Permanent Pacemaker Infection//Clinical Infectious Diseases. 2007. N 2 (45). P. 166 - 173.

279. Sohail M.R. [et al.]. Infective Endocarditis Complicating Permanent Pacemaker and Implantable Cardioverter - Defibrillator Infection//Mayo Clinic Proceedings. 2008. N 1 (83). P. 46 - 53.

280. Sousa C. [et al.]. Infective endocarditis in intravenous drug abusers: an update//European Journal of Clinical Microbiology & Infectious Diseases. 2012. N 11 (31). P. 2905 - 2910.

281. Squires R.W. [et al.]. Progression of Exercise Training in Early Outpatient Cardiac Rehabilitation//Journal of Cardiopulmonary Rehabilitation and Prevention. 2018. N 3 (38). P. 139 - 146.

282. Stavi V. [et al.]. Comparison of Clinical Characteristics and Prognosis in Patients with Right - and Left - sided Infective Endocarditis//Rambam Maimonides Medical Journal. 2019. N 1 (10). P. e0003.

283. Steinbach W.J. [et al.]. A meta - analysis of medical versus surgical therapy for Candida endocarditis//Journal of Infection. 2005. N 3 (51). P. 230 - 247.

284. Stucki G. [et al.]. Rationale and principles of early rehabilitation care after an acute injury or illness//Disability and Rehabilitation. 2005. N 7 - 8 (27). P. 353 - 359.

285. Taha L., Stegger M., Staphylococcus lugdunensis: antimicrobial susceptibility and optimal treatment options//European Journal of Clinical Microbiology & Infectious Diseases. 2019. N 8 (38). P. 1449 - 1455.

286. Tam D.Y. [et al.]. Early vs Late Surgery for Patients With Endocarditis and Neurological Injury: A Systematic Review and Meta - analysis//Canadian Journal of Cardiology. 2018. Vol. 34. N 9. 1185 - 1199 p.

287. Tamura K. Clinical characteristics of infective endocarditis with vertebral osteomyelitis//Journal of Infection and Chemotherapy. 2010. N 4 (16). P. 260 - 265.

288. Tarakji K.G. [et al.]. Cardiac implantable electronic device infections: Presentation, management, and patient outcomes//Heart Rhythm. 2010. N 8 (7). P. 1043 - 1047.

289. Tattevin P. [et al.]. Fungal endocarditis: current challenges//International Journal of Antimicrobial Agents. 2014. N 4 (44). P. 290 - 294.

290. Tattevin P. [et al.]. Update on blood culture - negative endocarditis// et Maladies Infectieuses. 2015. N 1 - 2 (45). P. 1 - 8.

291. Thornhill M.H. [et al.]. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions//European Heart Journal. 2018. N 7 (39). P. 586 - 595.

292. Thuny F. [et al.]. Risk of Embolism and Death in Infective Endocarditis: Prognostic Value of Echocardiography//Circulation. 2005. N 1 (112). P. 69 - 75.

293. Thuny F. [et al.]. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study//European Heart Journal. 2007. N 9 (28). P. 1155 - 1161.

294. Thuny F. [et al.]. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis//European Heart Journal. 2011. N 16 (32). P. 2027 - 2033.

295. Thuny F. [et al.]. Management of infective endocarditis: challenges and perspectives//The Lancet. 2012. N 9819 (379). P. 965 - 975.

296. Thuny F. [et al.]. Imaging investigations in infective endocarditis: Current approach and perspectives//Archives of Cardiovascular Diseases. 2013. N 1 (106). P. 52 - 62.

297. Tissot - Dupont H. [et al.]. High - dose trimethoprim - sulfamethoxazole and clindamycin for Staphylococcus aureus endocarditis//International Journal of Antimicrobial Agents. 2019. N 2 (54). P. 143 - 148.

298. Tornos P. [et al.]. Clinical Outcome and Long - Term Prognosis of Late Prosthetic Valve Endocarditis: A 20 - Year Experience//Clinical Infectious Diseases. 1997. N 3 (24). P. 381 - 386.

299. Torres - Tortosa M. [et al.]. Prospective evaluation of a two - week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis//European Journal of Clinical Microbiology & Infectious Diseases. 1994. N 7 (13). P. 559 - 564.

300. Truninger K. [et al.]. Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone?//Heart. 1999. N 6 (82). P. 714 - 720.

301. Alimoglu O. Splenic Abscess and Infarction - Rare Events for Which Surgery Is Mandatory//European Surgery. 2003. N 6 (35). P. 326 - 326.

302. Vahanian A. [et al.]. Guidelines on the management of valvular heart disease (version 2012)//European Heart Journal. 2012. N 19 (33). P. 2451 - 2496.

303. Veganzones J., Montero A., Maseda E. New evidence on the use of fosfomycin for bacteremia and infectious endocarditis//Revista espanola de quimioterapia: publicacion oficial de la Sociedad Espanola de Quimioterapia. 2019. Vol. 32. N Suppl 1. 25 - 29 p.

304. Vieira M.L.C. Repeated echocardiographic examinations of patients with suspected infective endocarditis//Heart. 2004. N 9 (90). P. 1020 - 1024.

305. Vilacosta I. [et al.]. Risk of embolization after institution of antibiotic therapy for infective endocarditis//Journal of the American College of Cardiology. 2002. N 9 (39). P. 1489 - 1495.

306. Vind S.H., Hess S. Possible role of PET/CT in infective endocarditis//Journal of Nuclear Cardiology. 2010. N 3 (17). P. 516 - 519.

307. Viswanathan M. [et al.]. Interventions to Improve Adherence to Self - administered Medications for Chronic Diseases in the United States//Annals of Internal Medicine. 2012. N 11 (157). P. 785.

308. Waite I. [et al.]. Home - based preoperative rehabilitation (prehab) to improve physical function and reduce hospital length of stay for frail patients undergoing coronary artery bypass graft and valve surgery//Journal of Cardiothoracic Surgery. 2017. N 1 (12). P. 91.

309. Wang A. Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis//JAMA. 2007. N 12 (297). P. 1354.

310. Watkins R.R., Lemonovich T.L., File T.M. An evidence - based review of linezolid for the treatment of methicillin - resistant Staphylococcus aureus (MRSA): Place in therapy//Core Evidence. 2012. Vol. 7. 131 - 143 p.

311. Wellens F. [et al.]. Prophylaxis in cardiac surgery. A controlled randomized comparison between cefazolin and cefuroxime//European journal of cardio - thoracic surgery: official journal of the European Association for Cardio - thoracic Surgery. 1995. N 6 (9). P. 325 - 329.

312. White P.M. [et al.]. Intracranial Aneurysms: CT Angiography and MR Angiography for Detection - Prospective Blinded Comparison in a Large Patient Cohort//Radiology. 2001. N 3 (219). P. 739 - 749.

313. Wilkoff B.L. [et al.]. Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management//Heart Rhythm. 2009. N 7 (6). P. 1085 - 1104.

314. Wilson L.E. [et al.]. Prospective Study of Infective Endocarditis among Injection Drug Users//The Journal of Infectious Diseases. 2002. N 12 (185). P. 1761 - 1766.

315. Wilson W. [et al.]. Prevention of infective endocarditis: Guidelines from the American Heart Association//The Journal of the American Dental Association. 2007. N 6 (138). P. 739 - 760.

316. Wilson W.R. [et al.]. Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement from the American Heart Association//Circulation. 2021. (143). P. E963 - E978.

317. Wojda T.R. [et al.]. Septic Embolism: A Potentially Devastating Complication of Infective Endocarditis InTech, 2016.

318. Yew H. Sen, Murdoch D.R. Global Trends in Infective Endocarditis Epidemiology//Current Infectious Disease Reports. 2012. N 4 (14). P. 367 - 372.

319. Yu C.H.Y., Minnema B.J., Gold W.L. Bacterial infections complicating tongue piercing//Canadian Journal of Infectious Diseases and Medical Microbiology. 2010. N 1 (21). P. e70 - e74.

320. Yuan X.C. [et al.]. Diagnosis of infective endocarditis using echocardiography//Medicine (United States). 2019. N 38 (98).

321. Yung D. [et al.]. Antimicrobials for right - sided endocarditis in intravenous drug users: A systematic review//Journal of Antimicrobial Chemotherapy. 2007. Vol. 60. N 5. 921 - 928 p.

322. Zasowski E.J. [et al.]. Multicenter observational study of ceftaroline fosamil for methicillin - resistant Staphylococcus aureus bloodstream infections//Antimicrobial Agents and Chemotherapy. 2017. N 2 (61).

323. Алехин М.Н., Рыбакова М.К., Сидоренко Б.А. Б.О.М. Значение эхокардиографии в диагностике инфекционного эндокардита//Кардиология. 2005. N 6. С. 4 - 13.

324. Андреева Н.С., Реброва О.Ю. [и др.]. Системы оценки достоверности научных доказательств и убедительности рекомендаций: сравнительная характеристика и перспективы унификации//Медицинские технологии. Оценка и выбор. 2012. (4). С. 10 - 24.

325. Бокерия Л.А., Асланиди И.П., Пурсанова Д.М., Мухортова О.В., Шурупова И.В., Сергуладзе С.Ю. Диагностика электродного инфекционного эндокардита методом ПЭТ/КТ с 18F - фтордезоксиглюкозой//Анналы аритмологии. 2019. N 16. С. 1.

326. Данилов А.И., Козлов Р.С., Козлов С.Н. Практика проведения микробиологической диагностики инфекционного эндокардита в Российской Федерации//Вестник Смоленской государственной медицинской академии. 2019. N 1 (18). С. 90 - 94.

327. Демин А.А., Дробышева В.П. Инфекционный эндокардит внутривенных наркоманов//Клин. мед. 2000. N 8 (78). С. 47 - 51.

328. Демин А.А. Кардиология. Национальное руководство. (под ред. акад. Е.В. Шляхто). Гл. 19 "Инфекционный эндокардит". 3 - е изд. М.: ГЭОТАР - Медиа, 2018. 816 с. (с. 597 - 616).

329. Муратов Р.М., Амирагов Р.И., Бабенко С.И. Инфекционный эндокардит (ИЭ)//Клинические рекомендации Министерства здравоохранения Российской Федерации. 2016. С. 50.

330. Николаевский Е.Н. Инфекционный эндокардит как медико - социальная проблема современной России//Новая наука: стратегии и векторы развития. 2016. N 88 (6 - 2). С. 26 - 29.

331. Поляков В.П., Николаевский Е.Н., Хубулава Г.Г., Шустов С.Б. Инфекционный эндокардит (современное состояние проблемы). Самара, 2007. 340 с.

332. Приказ Министерства здравоохранения РФ от 29 декабря 2012 г. N 1705н "О порядке организации медицинской реабилитации".

333. Рыбка М.М. Протоколы анестезиологического обеспечения рентгенэндоваскулярных и диагностических процедур, выполняемых у кардиохирургических пациентов различных возрастных групп. Методические рекомендации 2018.

334. Тюрин В.П. Инфекционные эндокардиты. М.: ГЭОТАР - Медиа, 2012. 242 - 243 с.

335. Федорова Т.А., Тазина С.Я., Семененко Н.А., Сотникова Т.И. Актуальные проблемы инфекционного эндокардита//Вестник Национального медико - хирургического центра им. Н.И. Пирогова. 2014. N 1. С. 125 - 127.

336. Шевченко Ю.Л. Инфекционный эндокардит. Руководство по кардиологии в четырех томах. Том 4: Заболевания сердечно - сосудистой системы (II): под ред. акад. Е.И. Чазова. М.: Практика, 2014. 453 - 495 с.

337. Федеральное агентство по техническому регулированию и метрологии. Национальный стандарт Российской Федерации. ГОСТР 52379 - 2005. Надлежащая клиническая практика. М., 2005.

338. Федеральная служба государственной статистики (Росстат) [Электронный ресурс]. URL: www.gks.ru.

339. Эпидемиологический словарь, 4 - е изд. под ред. Дж. М. Ласта для Международной эпидемиологической ассоциации. М., 2009. 316 с.